← FDA Drug Approvals (Drugs@FDA)

BENDAMUSTINE HYDROCHLORIDE

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2022-12-15

Drug application

FDA Application #

NDA216078

Application type

New Drug Application

Brand name

BENDAMUSTINE HYDROCHLORIDE

Generic name

BENDAMUSTINE HYDROCHLORIDE

Active ingredients

BENDAMUSTINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2022-12-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown